AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

Amit G. Singal, Josep M. Llovet, Mark Yarchoan, +13

Hepatology

Cancer ManagementPathologyAasld Practice GuidanceAlice C.Comparative Literature +17

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, +33

Journal of the National Comprehensive Cancer Network

Surgical OncologyCancer ManagementPathologyCholangiopathiesNccn Guidelines Recommendations +20

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Ghassan K. Abou‐Alfa, Teresa Macarulla, Milind Javle, +23

The Lancet Oncology

Gastrointestinal OncologyMedicineBiliary CancerPharmacologyPathology +6

Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

Cristina R. Ferrone, Giovanni Marchegiani, Theodore S. Hong, +18

Annals of Surgery

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

Milind Javle, Maeve A. Lowery, Rachna T. Shroff, +26

Journal of Clinical Oncology

Surgical OncologyPathologyPhase Ii StudyFgfr2 FusionsOncology +15

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma

Janet E. Murphy, Jennifer Y. Wo, David P. Ryan, +15

JAMA Oncology

Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Lipika Goyal, Supriya K. Saha, Leah Y. Liu, +29

Cancer Discovery

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina, +44

Nature Medicine

Gastrointestinal OncologyTumor HeterogeneityMedicineCancer DetectionGastrointestinal Cancers +9

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer

Janet E. Murphy, Jennifer Y. Wo, David P. Ryan, +28

JAMA Oncology

Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma

Lipika Goyal, Funda Meric‐Bernstam, Antoine Hollebecque, +27

New England Journal of Medicine